Mid-Year Oncology Review 2025: History Informs the Future
Mid-Year Oncology Review 2025: History Informs the Future

Mid-Year Oncology Review 2025: History Informs the Future

What are the promises and limitations of different therapeutic modalities in solid tumors? As we approach the mid-year point, we reflect on the advancements in oncology in recent years.

Ipsos Mid Year Oncology Review 2025 - History Informs the FutureIpsos explores challenges and opportunities in the development of emerging therapeutic modalities aimed at addressing solid tumors as well as prominent topics in the field including the dominance of small molecules as a time-tested and well-established modality that nonetheless continues to lead in FDA approval numbers each year; the potential of cancer vaccines to break through to the forefront owing to the opportunities created by mRNA-based neoantigens; and the journey of cell therapies as they start to penetrate solid tumor applications.

In this white paper, supported by Ipsos’ survey of oncologists based in the US, as well as KOL interviews, we reveal 5 key themes in oncology and how past lessons inform the innovations of today.

Sign up to access the white paper

The author(s)

  • Joel Sandler, PhD
    Associate Partner, Healthcare Advisory
  • Eric Blouin
    Senior Vice President, Healthcare Custom

Related news

  • [WEBINAR] KEYS: The Middle Class in Crisis?
    Consumers Events replay

    [WEBINAR] KEYS: The Middle Class in Crisis?

    Join Ipsos for its complimentary KEYS webinar series dedicated to helping brands and organizations better understand the dynamics of today as they prepare for tomorrow.
  • Automotive Disruption and Trends Webinar
    Consumers Webinar

    Automotive Disruption and Trends Webinar

    Please join Ipsos and SAA for a discussion on the future of mobility based on insights from the 2025 Ipsos Navigator Study.
  • Obesity Week
    Public Health Event

    Obesity Week

    This is a conference that encompasses the full spectrum of obesity science: from basic science research, to translational research and clinical application, to public policy; from diet, exercise, lifestyle, and psychology to medical and surgical interventions; from pediatric to geriatric to underserved populations.